COVID-19

5 November - Joanne Davies

As part of the UK Government's emergency legislation measures to tackle the coronavirus pandemic, a significant change was made to Statutory Sick Pay (SSP), effective from 13 March 2020. If... Read More

3 November - Paul Caldicott

Insolvency and Business Support experts Paul Caldicott and Roisin Gallop look at the impact of COVID-19 on Individual Voluntary Agreements (IVA's). This article was first published by the Institute Of... Read More

3 November - Debra Gers

In a surprising development on 31 October, the Prime Minister announced a month long lockdown for England starting on 5 November. He also announced that the furlough scheme would not... Read More

3 November - Giovanni Basiletti

Potentially, the Corporate Insolvency and Governance Act 2020 (CIGA) is a piece of legislation that could wreak significant harm on the construction industry supply chain. Read More

3 November - Giovanni Basiletti

Having summarised the changes introduced by the Corporate Insolvency and Governance Act 2020 (CIGA), we now look at how these affect contractual rights to terminate under construction and engineering contracts. Read More

3 November - Giovanni Basiletti

The Corporate Insolvency and Governance Act 2020 (CIGA) came into effect on 26 June 2020, introducing significant changes to contracts for the supply of goods and services, including the majority,... Read More

2 November - Robert Cherry

With the COVID-19 pandemic continuing to have significant adverse effects on businesses and economies worldwide, the UK government is reviewing and revising its measures aimed at mitigating the financial impact... Read More

30 October - Gemma Casey

This month starts the one year countdown until major changes to the way certain foods are labelled within the UK are introduced. On 1 October 2021, new allergen labelling laws... Read More

28 October - Tim Forer

It was on 20 March that the Chancellor announced the temporary introduction of the Coronavirus Job Retention Scheme, more commonly known as the furlough scheme. The practical implications of this... Read More

23 October - Gemma Casey

The Government anticipates that the Medicines and Healthcare Products Regulatory Agency ("MHRA") will make use of its powers under reg.174 of the Human Medicines Regulations 2012 ("HMRs"), and temporarily authorise... Read More

23 October - Gemma Casey

The Medicines and Healthcare Products Regulatory Agency ("MHRA") has the power under reg.174 of the Human Medicines Regulations 2012 ("HMRs"), to temporarily authorise use of an unlicensed vaccine in response... Read More

23 October - Gemma Casey

The UK Government has set out proposed changes to the way in which medicines in the UK are authorised for use in a recent consultation paper, specifically referencing COVID-19 vaccines. Read More